- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and serological evaluation of a novel CENP-A peptide based ELISA ; volume:12 ; number:3 ; day:20 ; month:5 ; year:2010 ; pages:1-14 ; date:6.2010
Arthritis Research & Therapy ; 12, Heft 3 (20.5.2010), 1-14, 6.2010
- Urheber
-
Mahler, Michael
- Beteiligte Personen und Organisationen
-
Maes, Liesbeth
Blockmans, Daniel
Westhovens, Rene
Bossuyt, Xavier
Riemekasten, Gabriela
Schneider, Sandra
Hiepe, Falk
Swart, Andreas
Gürtler, Irmgard
Egerer, Karl
Fooke, Margrit
Fritzler, Marvin J.
SpringerLink (Online service)
- DOI
-
10.1186/ar3029
- URN
-
urn:nbn:de:1111-2016050315695
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahler, Michael
- Maes, Liesbeth
- Blockmans, Daniel
- Westhovens, Rene
- Bossuyt, Xavier
- Riemekasten, Gabriela
- Schneider, Sandra
- Hiepe, Falk
- Swart, Andreas
- Gürtler, Irmgard
- Egerer, Karl
- Fooke, Margrit
- Fritzler, Marvin J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Novel approaches for formyl peptide receptor-based clinical applications
Erratum to: Evaluation of the Clinical Value of ELISA based on MPT64 Antibody Aptamer for Serological Diagnosis of Pulmonary Tuberculosis
Erratum to: Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
Late-age onset systemic sclerosis—clinical and serological characteristics
Clinical and serological follow-up of patients with WDEIA
A novel natriuretic peptide
Bioactive properties and clinical safety of a novel milk protein peptide
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA
Correction: Late-age onset systemic sclerosis—clinical and serological characteristics
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Novel approaches for formyl peptide receptor-based clinical applications
Erratum to: Evaluation of the Clinical Value of ELISA based on MPT64 Antibody Aptamer for Serological Diagnosis of Pulmonary Tuberculosis
Erratum to: Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
Late-age onset systemic sclerosis—clinical and serological characteristics
Clinical and serological follow-up of patients with WDEIA
A novel natriuretic peptide
Bioactive properties and clinical safety of a novel milk protein peptide
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA
Correction: Late-age onset systemic sclerosis—clinical and serological characteristics
Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Novel approaches for formyl peptide receptor-based clinical applications
Erratum to: Evaluation of the Clinical Value of ELISA based on MPT64 Antibody Aptamer for Serological Diagnosis of Pulmonary Tuberculosis
Erratum to: Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
Late-age onset systemic sclerosis—clinical and serological characteristics
Clinical and serological follow-up of patients with WDEIA
A novel natriuretic peptide
Bioactive properties and clinical safety of a novel milk protein peptide
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA